Ingelvac PCV FLEX
Porcine circovirus vaccine (inactivated)
Table of contents
Overview
The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
Authorisation details
| Product details | |
|---|---|
| Name |
Ingelvac PCV FLEX
|
| Agency product number |
EMEA/V/C/004645
|
| Active substance |
porcine circovirus type 2 ORF2 protein
|
| International non-proprietary name (INN) or common name |
Porcine circovirus vaccine (inactivated)
|
| Species |
Pigs
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AA07
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
| Revision |
2
|
| Date of issue of marketing authorisation valid throughout the European Union |
24/05/2017
|
| Contact address |
Binger Strasse 173 |
Product information
24/11/2017 Ingelvac PCV FLEX - EMEA/V/C/004645 - IG/0855/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for suidae
Therapeutic indication
For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2)